Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 739

Related Articles by Review for PubMed (Select 16805772)

1.

The chemical biology of clinically tolerated NMDA receptor antagonists.

Chen HS, Lipton SA.

J Neurochem. 2006 Jun;97(6):1611-26. Review.

PMID:
16805772
3.
4.
6.

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

Kornhuber J, Weller M.

Biol Psychiatry. 1997 Jan 15;41(2):135-44. Review.

PMID:
9018383
7.

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

Parsons CG, Danysz W, Quack G.

Neuropharmacology. 1999 Jun;38(6):735-67. Review.

PMID:
10465680
8.

Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

Sonkusare SK, Kaul CL, Ramarao P.

Pharmacol Res. 2005 Jan;51(1):1-17. Review.

PMID:
15519530
9.

Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.

Lipton SA.

Nat Rev Drug Discov. 2006 Feb;5(2):160-70. Review.

PMID:
16424917
10.

Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?

Smith PF.

Curr Opin Investig Drugs. 2003 Jul;4(7):826-32. Review.

PMID:
14619404
11.

Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.

Seki M, Lipton SA.

Prog Brain Res. 2008;173:495-510. doi: 10.1016/S0079-6123(08)01134-5. Review.

PMID:
18929130
12.

Trialkylglycines: a new family of compounds with in vivo neuroprotective activity.

Sánchez-Pérez AM, Montoliu C, Felipo V.

CNS Drug Rev. 2003 Fall;9(3):263-74. Review.

PMID:
14530798
13.

The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.

Rogawski MA, Wenk GL.

CNS Drug Rev. 2003 Fall;9(3):275-308. Review.

PMID:
14530799
14.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res. 2012 Jul;9(6):746-58. Review.

PMID:
21875407
16.

Mechanism of action of memantine.

Johnson JW, Kotermanski SE.

Curr Opin Pharmacol. 2006 Feb;6(1):61-7. Epub 2005 Dec 20. Review.

PMID:
16368266
17.

[The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences].

Turski L.

Arzneimittelforschung. 1990 May;40(5):511-4. Review. German.

PMID:
1974426
18.

The NMDA receptor complex: a long and winding road to therapeutics.

Wood PL.

IDrugs. 2005 Mar;8(3):229-35. Review.

PMID:
15772895
20.

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.

Lipton SA.

Surv Ophthalmol. 2003 Apr;48 Suppl 1:S38-46. Review.

PMID:
12852433
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk